Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Maher

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
Biochemical Society Transactions|November 24, 2018
The role of the interleukin (IL)-6/IL-6 receptor axis in cancerMustafa Yassin Taher, David Marc Davies, John Maher
Foot & Ankle Specialist|April 28, 2017
A Midterm Review of Lesser Toe Arthrodesis With an Intramedullary ImplantJames Lee Harmer, Anthony Wilkinson, Anthony John Maher
Immunotherapy|January 28, 2017
Prospects for immunotherapy of acute myeloid leukemia using γδ T cellsLeena Halim, Ana Catarina Parente-Pereira, John Maher
Cells|July 27, 2022
CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor ReceptorDaniela Yordanova Achkova, Richard Esmond Beatson, John Maher
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2019
New Developments in Imaging Cell-Based TherapyOlivier Martinez, Jane Sosabowski, John Maher, et al.
Palliative & Supportive Care|July 18, 2023
The realities of Medical Assistance in Dying in CanadaRamona Coelho, John Maher, K Sonu Gaind, et al.
Clinical and Translational Radiation Oncology|September 3, 2020
The eIF4A inhibitor silvestrol sensitizes T-47D ductal breast carcinoma cells to external-beam radiotherapyThomas E Webb, Marc Davies, John Maher, et al.
Palliative & Supportive Care|August 10, 2023
The realities of Medical Assistance in Dying in Canada - CORRIGENDUMRamona Coelho, John Maher, K Sonu Gaind, et al.
Biochemical Society Transactions|April 13, 2016
Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?Dominic Boardman, John Maher, Robert Lechler, et al.
Nature Biotechnology|December 26, 2001
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptorJohn Maher, Renier J Brentjens, Gertrude Gunset, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
Biochemical Society Transactions|November 24, 2018
The role of the interleukin (IL)-6/IL-6 receptor axis in cancerMustafa Yassin Taher, David Marc Davies, John Maher
Foot & Ankle Specialist|April 28, 2017
A Midterm Review of Lesser Toe Arthrodesis With an Intramedullary ImplantJames Lee Harmer, Anthony Wilkinson, Anthony John Maher
Immunotherapy|January 28, 2017
Prospects for immunotherapy of acute myeloid leukemia using γδ T cellsLeena Halim, Ana Catarina Parente-Pereira, John Maher
Cells|July 27, 2022
CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor ReceptorDaniela Yordanova Achkova, Richard Esmond Beatson, John Maher
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 14, 2019
New Developments in Imaging Cell-Based TherapyOlivier Martinez, Jane Sosabowski, John Maher, et al.
Palliative & Supportive Care|July 18, 2023
The realities of Medical Assistance in Dying in CanadaRamona Coelho, John Maher, K Sonu Gaind, et al.
Clinical and Translational Radiation Oncology|September 3, 2020
The eIF4A inhibitor silvestrol sensitizes T-47D ductal breast carcinoma cells to external-beam radiotherapyThomas E Webb, Marc Davies, John Maher, et al.
Palliative & Supportive Care|August 10, 2023
The realities of Medical Assistance in Dying in Canada - CORRIGENDUMRamona Coelho, John Maher, K Sonu Gaind, et al.
Biochemical Society Transactions|April 13, 2016
Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?Dominic Boardman, John Maher, Robert Lechler, et al.
Nature Biotechnology|December 26, 2001
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptorJohn Maher, Renier J Brentjens, Gertrude Gunset, et al.
Pageof 14